COL22A1 expression identifies aggressive glioma and independently predicts survival through integrated multiomics and clinical validation
Abstract Background Gliomas, especially IDH‑wildtype astrocytomas, remain lethal despite multimodal therapy. Collagen type XXII alpha-1 (COL22A1) exhibits oncogenic activity in other cancers but remains underexplored in brain tumors. We asked whether its expression, cellular origin, and spatial cont...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Springer
2025-10-01
|
| Цуврал: | Discover Oncology |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1007/s12672-025-03723-5 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
